RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Systematic symptom management in the IMPACT Consortium
rationale and design for 3 effectiveness-implementation trials
Smith, A. W., DiMartino, L., Garcia, S. F., Mitchell, S. A., Ruddy, K. J., Smith, J. D., Wong, S. L., Cahue, S., Cella, D., Jensen, R. E., Hassett, M. J., Hodgdon, C., Kroner, B., Osarogiagbon, R. U., Popovic, J., Richardson, K., Schrag, D., Cheville, A. L., & IMPACT Consortium
(2023). Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials. JNCI Cancer Spectrum, 7(6), Article pkad073. https://doi.org/10.1093/jncics/pkad073
Cancer and its treatment produce deleterious symptoms across the phases of care. Poorly controlled symptoms negatively affect quality of life and result in increased health-care needs and hospitalization. The Improving the Management of symPtoms during And following Cancer Treatment (IMPACT) Consortium was created to develop 3 large-scale, systematic symptom management systems, deployed through electronic health record platforms, and to test them in pragmatic, randomized, hybrid effectiveness and implementation trials. Here, we describe the IMPACT Consortium's conceptual framework, its organizational components, and plans for evaluation. The study designs and lessons learned are highlighted in the context of disruptions related to the COVID-19 pandemic.
